Skip to main content

At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer

CBE ID
0225
1.4 Project
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of patients, age >=18 and <= 120 at diagnosis, who have their first diagnosis of cancer (epithelial malignancy), whose primary tumor is of the colon, and had at least 12 regional lymph nodes removed and pathologically examined for resected colon cancer

        • 1.14 Numerator

          At least 12 regional lymph nodes are removed and pathologically examined

        • 1.15 Denominator

          Include if all of the following characteristics are identified:
          Men or women
          Age >= 18 and <= 120 at time of diagnosis
          Any sequence of malignant primary tumor
          Epithelial malignancy only
          Invasive tumors
          Primary tumors of the colon
          All or part of 1st course of treatment performed at the reporting facility
          Surgical procedure of the primary site at the reporting facility

        • Exclusions

          Exclude, if any of the following characteristics are identified:
          Under age 18 or over 120 at time of diagnosis
          Tumor not originating in the colon
          Non-epithelial malignancies
          Non-invasive tumors
          Stage 0, in-situ tumor
          Stage IV, metastatic tumor
          None of 1st course therapy performed at reporting facility
          No surgical procedure of the primary site at the reporting facility
          Perforation of the primary site
          Acute obstruction
          Positive FNA; nodes removed surgically were negative due to neo-adjuvant chemo

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Cancer Spring Cycle 2020
          Initial Endorsement
          Last Updated
          Removal Date